Moody's: Orthofix unchanged

Moody's Investors Service said that it acknowledges several recent developments at Orthofix International NV, which appear to signal early progress in the stabilization of the spinal implant business (i.e, Blackstone) as well as improved liquidity.

However, the agency said that there is currently no change to the outlook, which remains negative, as it believes that there continues to be risks associated with litigation, near-term product transitions and the continued restructuring of the spine division.

There is no change to the B1 corporate family rating or the B2 probability of default rating, the agency noted.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.